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Correction: “Reduction in BMI z-score and
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adiposity intervention study - a hospital/public
health nurse combined treatment.”
Magnhild L Pollestad Kolsgaard1*, Geir Joner1,2, Cathrine Brunborg3, Sigmund A Anderssen4, Serena Tonstad5,6
and Lene Frost Andersen6
Correction
After publication of this work [1], it came to our atten-
tion that the laboratory we use changed the method of
analysis for insulin and C-peptide during our data col-
lection. Before March 2007 the method used for insulin
was competitive radioimmunoassay (Linco Research Inc,
St Charles, MO, USA) and for C-peptide competitive
luminoimmunoassay (Immulite 2000, Diagnostic Pro-
ducts Corporation, CA, USA). After March 2007 non-
competitive immunofluorometric assays (DELFIA kit
form Wallac OY, Turku, Finland) were used.
We have therefore recalculated the insulin and C-
peptide values analyzed after March 2007, and repeated
the statistical analyses involving insulin, C-peptide and
HOMA-IR.
Corrections in the Abstract
In Results the fifth sentence should have read:
“Even a very small reduction in BMI z-score (group 3)
was associated with significantly lower total cholesterol,
LDL cholesterol and total/HDL cholesterol ratio.”
Explanation:
After recalculation the significant reduction in insulin
in the group with a very small reduction in BMI z-score
disappeared. None of the groups had significant
improvements in insulin concentration (the improve-
ments in group 1 and 2 were of borderline significance).
The seventh sentence should have read:
“An increase in BMI z-score was associated with a
worsening of HOMA-IR, insulin, C-peptide and total/
HDL cholesterol ratio.”
Explanation:
The group with an increase in BMI z-score had a wor-
sening in HOMA-IR and insulin in addition to C-
peptide and total/HDL cholesterol ratio as previously
reported.
Corrections in the Main manuscript
Results
In the section “Baseline characteristics” on page 4
The fourth-fifth sentence should have read:
“Insulin, C-peptide, triglycerides and aerobic fitness at
baseline also differed between the groups, but the other
seven parameters did not differ between the groups, see
corrected version of Additional file 1. The group with
the largest reduction in BMI z-score (Group 1) had sig-
nificantly higher aerobic fitness and significantly lower
insulin and C-peptide concentration than the three other
groups (data not shown).”
Explanation:
Insulin should be added to the list with metabolic
parameters that differed between the groups at base-
line. Moreover the group with the largest reduction
in BMI z-score (Group 1) had significant lower insu-
lin in addition to lower C-peptide and higher aerobic
fitness as previously reported.
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In the section “Changes in metabolic parameters
and aerobic activity according to changes in BMI
z-score after one year intervention” on page 4
The second sentence should have read:
“We also found significant improvements in total chol-
esterol, LDL cholesterol and total cholesterol/HDL chol-
esterol ratio in the total group (data not shown).”
Explanation:
The significant reduction in HOMA-IR and insulin
after one year intervention in the total group disappear.
The tenth sentence (start of paragraph 3) in the same
section should have read:
“A very small reduction in BMI z-score after one year
follow-up (group 3) was associated with significantly
lower total cholesterol, LDL and total cholesterol/HDL
cholesterol ratio, see corrected version of Additional file
2.
Explanation:
The significant reduction in insulin in the group with
a very small reduction in BMI z-score disappeared. None
of the groups had significant improvements in insulin
concentration (the improvements in group 1 and 2 were
of borderline significance).
The eleventh sentence (paragraph 3) in the same
section
The phrase “The improvement in HOMA-IR was of
borderline significance in this group” should be deleted.
Explanation:
The improvement in HOMA-IR was no longer border-
line significant in the group with the smallest reduction
in BMI z-score (group 3).
The thirteenth sentence (paragraph 3) in the same sec-
tion should have read:
“The group with an increase in BMI z-score (group
4) had a significant increase in HOMA-IR, insulin,
C-peptide and total cholesterol/HDL cholesterol ratio
after the intervention.”
Explanation:
The group with an increase in BMI z-score (group 4)
got a worsening in HOMA-IR and insulin in addition to
C-peptide and total/HDL cholesterol ratio as we previ-
ously reported.
Discussion
The thirteenth sentence (paragraph three) on page 5
should have read:
“The group in our study with the lowest BMI z-score
initially also had the lowest insulin value at the begin-
ning of the intervention. This group also tended to have
the lowest HOMA-IR value at baseline even though the
difference was not statistically significant.”
Explanation:
We have written that the group in our study with
the lowest BMI z-score initially (that is the same
group that reduced their BMI z-score the most,
group 1) also tended to have the lowest HOMA-IR
and insulin values at the beginning of the interven-
tion even though the difference was not statistically
significant. The difference between group 1 and the
three other groups according to insulin now become
statistically significant.
The fifteenth sentence (start of paragraph four) on
page 5 should have read:
“We found that a reduction in BMI z-score ≥0.23
(group 4) improved insulin resistance.”
Explanation:
It is no longer correct that the group with a very
small reduction in BMI z-score (≥0.00-< 0.10)
improved insulin and insulin resistance. Insulin re-
sistance only improved in the group with the largest
reduction in BMI z-score, and the improvement in
insulin was of borderline significance in this group.
The twenty-first sentence (paragraph four) on page 5
should have read:
“Like Reinehr et al we found an increase in insulin re-
sistance in the group with an increase in BMI z-score
[3,4]”.
Explanation:
The group with an increase in BMI z-score now got a
worsening in insulin resistance, like Reinehr earlier has
reported. The last part of the sentence “though C-
peptide concentrations increased, indicating increased
insulin production and future risk of diabetes” is no
longer relevant for our findings.
The twenty-fifth sentence (end of paragraph four) on
page 5 “No change in glucose and a simultaneous lower-
ing of insulin indicates that the insulin resistance is
improved, and less insulin is needed to maintain the
same glucose concentration” should be deleted.
Explanation:
This is no longer relevant for our findings since insulin
did not improve in any of the groups.
Conclusions
The first and second sentences in the conclusion should
have read:
“In conclusion even a modest reduction in BMI z-
score after one year intervention was associated with
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improvement in total-, LDL, and total/HDL cholesterol.
An increase in BMI z-score during the one year period
was associated with worsening of HOMA-IR, insulin, C-
peptide and total/HDL cholesterol.”
Explanation:
The improvement in insulin in the group with the
small reduction in BMI z-score disappeared (group 3)
and the group with increased BMI z-score had an wor-
sening of HOMA-IR and insulin in addition to C-
peptide and total/HDL cholesterol
Additional files
Additional file 1: Corrected Table 1. The values that changed are
shown in bold.
Additional file 2: Corrected Table 2. The values that changed are
shown in bold.
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